Patients’ perceptions of the side-effects of prostate cancer treatment—A qualitative interview study

2006 ◽  
Vol 63 (4) ◽  
pp. 911-919 ◽  
Author(s):  
Ida Joanna Korfage ◽  
Tony Hak ◽  
Harry J. de Koning ◽  
Marie-Louise Essink-Bot
2013 ◽  
Vol 106 ◽  
pp. S376
Author(s):  
A.G. Martin ◽  
W. Foster ◽  
E. Vigneault ◽  
N. Vrafalvy ◽  
S. Aubin ◽  
...  

2020 ◽  
Vol 38 (4) ◽  
pp. 439-446
Author(s):  
Sigrid Brisson Nielsen ◽  
Olivia Spalletta ◽  
Mads Aage Toft Kristensen ◽  
John Brodersen

Nutrients ◽  
2014 ◽  
Vol 6 (10) ◽  
pp. 4491-4519 ◽  
Author(s):  
Andrea Dueregger ◽  
Isabel Heidegger ◽  
Philipp Ofer ◽  
Bernhard Perktold ◽  
Reinhold Ramoner ◽  
...  

2021 ◽  
Vol 8 ◽  
Author(s):  
Benedikt Hoeh ◽  
Stefan C. Müller ◽  
Luis A. Kluth ◽  
Mike Wenzel

The purpose of this narrative review is to discuss and highlight recently published studies regarding the surgical management of patients suffering from prostate cancer treatment complications. Focus will be put on the recalcitrant and more complex cases which might lead to urinary diversion as a definite, last resort treatment. It is in the nature of every treatment, that complications will occur and be bothersome for both patients and physicians. A small percentage of patients following prostate cancer treatment (radical prostatectomy, radiation therapy, or other focal therapies) will suffer side effects and thus, will experience a loss of quality of life. These side effects can persist for months and even years. Often, conservative management strategies fail resulting in recalcitrant recurrences. Prostate cancer patients with “end-stage bladder,” “devastated outlet,” or a history of multiple failed interventions, are fortunately rare, but can be highly challenging for both patients and Urologists. In a state of multiple previous surgical procedures and an immense psychological strain for the patient, urinary diversion can offer a definite, last resort surgical solution for this small group of patients. Ideally, they should be transferred to centers with experience in this field and a careful patient selection is needed. As these cases are highly complex, a multidisciplinary approach is often necessary in order to guarantee an improvement of quality of life.


Author(s):  
Sarah C. Kobrin ◽  
Alex Conway

Men diagnosed with early stage prostate cancer will very likely survive many years after their prostate cancer treatment, regardless of which standard treatment is used. This case study describes a situation in which all standard treatments are supported by evidence but side effects vary greatly. In this situation, a partnership is needed between the doctor and the patient to choose the best option. This case study gives a brief overview of the complexities of choosing a treatment for early state prostate cancer and how implementation science is needed to (1) consider effectiveness and implementation together and (2) identify factors that inhibit and enhance the implementation and sustainability of shared decision-making.


Sign in / Sign up

Export Citation Format

Share Document